Skip to main content
Clinical Trials/NCT03150927
NCT03150927
Unknown
Not Applicable

A Clinical Study to Determine the Effects of a Novel Probiotic Microbial Composite™ on Improving Digestive Health and Key Growth Parameters in Undernourished Young Children

Biowish Technologies, Inc.1 site in 1 country250 target enrollmentSeptember 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Quality of Life
Sponsor
Biowish Technologies, Inc.
Enrollment
250
Locations
1
Primary Endpoint
Acute diarrhea in children ages 3 years to 12 years
Last Updated
8 years ago

Overview

Brief Summary

This study is to determine if a novel bio-fermented Microbiotic Composite™ can improve the digestive health and subsequent growth and quality of life parameters in a selected group of children in a district in India.

Detailed Description

The Probiotic Microbial Composite™ is a multifaceted technology that encompasses three key areas, namely, prebiotics, probiotics and post-biotics. The first component, prebiotics, involve non-digestible food ingredients, typically oligosaccharides which act by beneficially affecting the host by stimulating growth, activity, or in fact both of specific intestinal bacteria. The probiotic component refers to the augmentation or addition of bacteria to enhance and support the various beneficial bacteria that are inherent to the gastrointestinal tract. The bio-fermented Microbiotic Composite™ is a consortium of bacteria which can play a significant physiological role as a probiotic. This theory, termed the microbial consortium theory suggests that rather than a cumulative effect by the bacteria, there is in fact combinatorial affect by the use of several species. The final component post-biotics, in general, mimic the beneficial health promoting effects of probiotics whilst avoiding the risk of taking live micro-organisms within the gastrointestinal tract, especially in populations such as infants and the elderly in whom the intestinal barriers, as well as, innate immune defenses can be impaired. The term typically encompasses a vast plethora of byproducts, know as metabolites, produced and secreted by the bacteria in response to their environment.

Registry
clinicaltrials.gov
Start Date
September 2017
End Date
September 2019
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Acute diarrhea in children ages 3 years to 12 years

Time Frame: 24 weeks

Subjects will be assessed as to severity of diarrhea using a standardized measure of diarrheal severity in pediatrics

Secondary Outcomes

  • Weight of healthy children aged 3 years to 12 years(2 years)
  • Serial assessment of healthy children aged 3 years to 12 years(2 years)
  • Height of healthy children aged 3 years to 12 years(2 years)

Study Sites (1)

Loading locations...

Similar Trials